All Programs

Use the tool below to view all available Prova Series

A Global Health Crisis
A Global Health Crisis
MinuteCE®
A Global Health Crisis
1.25 program credits
- Donna Ryan, MD
1.25 program credits
Diagnosing Obesity: Beyond BMI
Diagnosing Obesity: Beyond BMI
MinuteCE®
Diagnosing Obesity: Beyond BMI
1.25 program credits
- Walmir Coutinho, MD
- Charles P. Vega, MD
1.25 program credits
MinuteCE®
Transforming Global Obesity Care: Empowering Clinicians With Comprehensive Strategies From Early Diagnosis to Patient-Centered Treatments
1.25 credits 7 episodes
- Charles P. Vega, MD
- Donna Ryan, MD
- Walmir Coutinho, MD
- Marta Comas
- Andreea Ciudin, MD, PhD
- Rita Nawar
- Nasreen Alfaris, MD, MPH
- Linong Ji, MD
1.25 credits 7 episodes
MinuteCE®
Idiopathic Multicentric Castleman Disease Patient Journey: Optimizing Best Practices to Improve Patient-Centric Outcomes
1.00 credit 9 episodes
- Corey Casper, MD, MPH
- Sudipto Mukherjee, MD, PhD, MPH
- Jovanna De La Pena
1.00 credit 9 episodes
Pharmacotherapy in Obesity: Current and Emerging Options
Pharmacotherapy in Obesity: Current and Emerging Options
MinuteCE®
Pharmacotherapy in Obesity: Current and Emerging Options
1.25 program credits
- Donna Ryan, MD
- Andreea Ciudin, MD, PhD
1.25 program credits
The Power of Shared Decision-Making in Obesity Care
The Power of Shared Decision-Making in Obesity Care
MinuteCE®
The Power of Shared Decision-Making in Obesity Care
1.25 program credits
- Charles P. Vega, MD
1.25 program credits
What’s New in Glaucoma Topical Therapies?
What’s New in Glaucoma Topical Therapies?
MinuteCE®
What’s New in Glaucoma Topical Therapies?
1.00 program credit
- Justin Schweitzer, OD, FAAO
- Sarah H. Van Tassel, MD
1.00 program credit
What’s New in Subconjunctival MIBS
What’s New in Subconjunctival MIBS
MinuteCE®
What’s New in Subconjunctival MIBS
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
What’s New in Schlemm’s Canal MIGS?
What’s New in Schlemm’s Canal MIGS?
MinuteCE®
What’s New in Schlemm’s Canal MIGS?
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
What’s New in Suprachoroidal MIGS?
What’s New in Suprachoroidal MIGS?
MinuteCE®
What’s New in Suprachoroidal MIGS?
1.00 program credit
- I. Paul Singh, MD
- Paul Petrakos, DO, MS
1.00 program credit
New Solutions for Optimizing IOP Control: A Case-Based Approach
New Solutions for Optimizing IOP Control: A Case-Based Approach
MinuteCE®
New Solutions for Optimizing IOP Control: A Case-Based Approach
1.00 program credit
- Sarah H. Van Tassel, MD
- Justin Schweitzer, OD, FAAO
1.00 program credit
3D Heads-Up Visualization: Cases in Glaucoma Surgery
3D Heads-Up Visualization: Cases in Glaucoma Surgery
MinuteCE®
3D Heads-Up Visualization: Cases in Glaucoma Surgery
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
3D Heads-Up Visualization: Tips for Getting Started in Glaucoma Surgery
3D Heads-Up Visualization: Tips for Getting Started in Glaucoma Surgery
MinuteCE®
3D Heads-Up Visualization: Tips for Getting Started in Glaucoma Surgery
1.00 program credit
- Paul Petrakos, DO, MS
- I. Paul Singh, MD
1.00 program credit
Biomarker-Directed Approaches for Frontline Treatment of Advanced Gastric/GEJ Cancers: The Evidence
Biomarker-Directed Approaches for Frontline Treatment of Advanced Gastric/GEJ Cancers: The Evidence
MinuteCE®
Biomarker-Directed Approaches for Frontline Treatment of Advanced Gastric/GEJ Cancers: The Evidence
1.25 program credits
- Sara Lonardi, MD
1.25 program credits
First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study
First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study
MinuteCE®
First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study
1.25 program credits
- Sara Lonardi, MD
1.25 program credits
Clinical Implications of Current Guidelines on First-Line Immunotherapy and PARP Inhibitors for TNBC
Clinical Implications of Current Guidelines on First-Line Immunotherapy and PARP Inhibitors for TNBC
MinuteCE®
Clinical Implications of Current Guidelines on First-Line Immunotherapy and PARP Inhibitors for TNBC
1.50 program credits
- Peter Schmid, FRCP, MD, PhD
1.50 program credits

All Programs

Popular

Title

Share on ReachMD